What is the recommended dose and dilution of Rapifen (alfentanil) for Rapid Sequence Intubation (RSI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alfentanil (Rapifen) Dosing for Rapid Sequence Intubation

For rapid sequence intubation (RSI), the recommended dose of alfentanil (Rapifen) is 20-50 μg/kg IV, administered over 3 minutes to minimize the risk of chest wall rigidity and respiratory depression. 1

Dosage Recommendations

Adult Dosing

  • Standard RSI dose: 20-50 μg/kg IV 1
  • Optimal dose for hemodynamic stability: 36-40 μg/kg IV 2
  • Elderly patients (65-80 years): 20 μg/kg IV provides optimal balance between intubation conditions and hemodynamic stability 3

Dilution and Administration

  • Administer slowly over 3 minutes to prevent chest wall rigidity 1
  • Can be given undiluted or diluted in normal saline
  • For a 70kg adult, a typical dose would be 1400-3500 μg (1.4-3.5 mg)

Clinical Considerations

Benefits of Alfentanil for RSI

  • Rapid onset of action (1-2 minutes) 4
  • Short duration (15-20 minutes) compared to other opioids 1
  • Effectively attenuates hemodynamic response to laryngoscopy and intubation 1
  • Provides analgesia during the procedure 5

Potential Adverse Effects

  • Chest wall rigidity: More common with rapid administration; administer slowly over 3 minutes 1
  • Respiratory depression: Have ventilatory support ready 1
  • Hypotension: Particularly in elderly, hypovolemic, or hemodynamically unstable patients 3
  • Bradycardia: Consider pre-treatment with anticholinergics in selected cases 1

Special Populations

Elderly Patients

  • Reduce dose to 20 μg/kg to minimize hypotension and bradycardia 3
  • Higher doses (25 μg/kg) associated with increased incidence of hypotension 3
  • Lower doses (10-15 μg/kg) may provide insufficient attenuation of intubation response 3

Patients with Liver Dysfunction

  • Reduce dose by 30-50% due to reduced clearance 1
  • Monitor more closely for prolonged effects 1

Practical Algorithm for Alfentanil Use in RSI

  1. Assess patient risk factors:

    • Age (elderly require lower doses)
    • Hemodynamic stability (hypotension risk)
    • Liver function (affects metabolism)
    • Concomitant medications
  2. Select appropriate dose:

    • Healthy adults: 36-40 μg/kg
    • Elderly (>65 years): 20 μg/kg
    • Liver dysfunction: Reduce by 30-50%
  3. Prepare medication:

    • Calculate total dose based on weight
    • Can be administered undiluted or diluted in normal saline
  4. Administration technique:

    • Administer slowly over 3 minutes
    • Follow with induction agent (e.g., propofol, etomidate)
    • Then administer neuromuscular blocking agent
  5. Monitor for adverse effects:

    • Have vasopressors ready for potential hypotension
    • Monitor for chest wall rigidity
    • Be prepared for respiratory support

Common Pitfalls and How to Avoid Them

  • Too rapid administration: Always administer over 3 minutes to prevent chest wall rigidity
  • Failure to adjust dose in elderly: Use 20 μg/kg in patients >65 years
  • Inadequate monitoring: Continuous BP and ECG monitoring essential
  • Not anticipating hypotension: Have vasopressors readily available
  • Overlooking drug interactions: Benzodiazepines can potentiate respiratory depression 4

Alfentanil provides excellent conditions for RSI when properly dosed and administered, but careful attention to dosing, administration technique, and patient factors is essential to maximize safety and efficacy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.